Paul F. Mansfield, MD

Professor
MD Anderson Cancer Center, United States

Presentation(s):

• 71: Phase I Trial of Intraperitoneal Paclitaxel in Patients with Gastric Adenocarcinoma and Peritoneal Carcinomatosis or Positive Peritoneal Cytology

  Thursday, March 21, 2024
  2:22pm – 2:32pm ET

• 89: Survival Outcomes in Patients with Resectable Gastric Cancer Treated with Total Neoadjuvant Therapy

  Friday, March 22, 2024
  10:32am – 10:42am ET

• 92: Phase I Trial of Short-Course Chemoradiotherapy followed by Chemotherapy as Total Neoadjuvant Therapy for Patients with Potentially Resectable Gastric Cancer

  Friday, March 22, 2024
  11:02am – 11:12am ET

• P52: Updated Report of a Randomized Trial for Appendiceal Neoplasm Ten Years After Cytoreduction and HIPEC With Mitomycin vs. Oxaliplatin

  Saturday, March 23, 2024
  9:07am – 9:13am ET